Vivos Therapeutics, Inc.VVOS決算レポート
Nasdaq · biotechnology
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| Armistice Capital, LLC | 4.99% | 250.3K | ▼ -5.00pp | 2024-11-14 |
| Coronado V Partners, LLC | 3.20% | 69.6K | — | 2024-02-14 |
| Ionic Ventures, LLC | 1.80% | 83.0K | ▼ -6.90pp | 2024-11-14 |
インサイダー取引
Net 90d: +$1.81M · buys $1.81M / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 1.04M | $1.34 | $1.40M |
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 308.8K | $1.34 | $413.9K |
1–2 of 2